ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646379 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646379; 2) Community: the network communities that were significantly associated with the response to NSC 646379; 3) Molecule: the relationships between components within communities and NSC 646379; 4) MDR: the compounds that were significantly associated with the NSC 646379.

NSC Compound Enrichment Correlation
NSC 698955 Null 0.0393863597626316 -0.0052632049
NSC 729838 3-{(2E)-3-[4-(1H-benzimidazol-2-yl)phenyl]triaz-2-enyl}propa n-1-ol 0.0393863597626316 0.040967445
NSC 745678 Null 0.0393863597626316 -0.12174565
NSC 754077 7-(3,4-dimethoxybenzyl)-6-phenyl-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole 0.0393863597626316 0.14117401
NSC 756363 GW804482X 0.0393863597626316 -0.080259702
NSC 62485 Null 0.0393863597626322 0.20716387
NSC 632134 Null 0.0393863597626322 0.28461343
NSC 648365 Insulin-Methotrexate conjugate 0.0406225271888773 0.2769979
NSC 658370 Null 0.0406225271888773 0.16294577
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0406225271888773 -0.074639681
Total:35  Current:25    [First] [Prev] [Next] [Last]